Maharashtra to get Rs 154 cr vaccines manufacturing plantIllustrative image – not actual.
Maharashtra will get Rs 154 crore vaccines manufacturing plant. The announcement was made by Maharashtra Chief Minister Uddhav Thackeray during a visit to Haffkine Bio-Pharmaceutical Corporation. 
 
The CM had urged the Centre to grant permission to the state-owned institute to manufacture COVID-19 vaccines.
 
The plant will be a joint venture between Haffkine and Bharat Biotech. The necessary follow-up will be done to ensure that more vaccination centres are set up and the process for Haffkine to secure permission to produce vaccines is speeded up. 
 
The detailed proposal will be sent to the Central government. Haffkine can acquire technology to manufacture vaccines through the Indian Council for Medical Research or it can be worked out on a fill-and-finish basis through which 126 lakh vaccines can be produced. 
 
Under Phase-I, Covaxin will undergo repacking and filling as per the requirement. The production will be then continued till the requirement of Covaxin is met and later the plant will be utilised for production of rabies vaccine.
← All latest storiesBack to top →